In a recent update about the COVID-19, there has been an upsurge in cases as the delta variant continues to spread in the country.

Previously, more than 700,000 United States residents have died due to COVID-19 whereas, more than 4.8 million people globally have died from the deadly virus, according to the data compiled by the Center for Systems Science and Engineering at Johns Hopkins University.

Recent statistics from the CDC revealed that just around 65% of the U.S. residents aged 12 and above are now fully vaccinated with double shots for COVID-19.

Pfizer submits data on COVID-19 vaccine for kids ages 5 to 11 to FDA | Top COVID headlines

Considering the recent increase in the COVID-19 cases, Pfizer has submitted an urgent request to the FDA for authorizing the use of vaccines to children ages 5 to 11 years. This will bring shots for the school-goers kids one step closer to the battle against COVID-19.

Both Pfizer and BioNTech SE announced the news Thursday through a tweet by the company. FDA also scheduled a meeting to review the clinical trial of the vaccines created for kids on October 26.

President Biden’s legal adviser, Anthony Fauci, has advised emergency clearance should be issued on the vaccine before Halloween. The vaccine shots for kids should commence before Thanksgiving.

Many parents have already expressed their concerns about the vaccine shots necessary for their children since schools have re-opened in the U.S. Even so, the FDA will be looking after all the necessary information and clinical trials and will be giving a final go-ahead.

The vaccine will likely be available in early November after approval by the FDA.